Path of exploration for the optimal antithrombotic treatment strategy for patients with coronary heart disease.
10.3760/cma.j.cn112148-20220324-00206
- Author:
Yang LI
1
;
Ya Ling HAN
1
Author Information
1. Department of Cardiology, General Hospital of Northern Theater Command, Shenyang 110016, China.
- Publication Type:Journal Article
- MeSH:
Acute Coronary Syndrome/drug therapy*;
Anticoagulants/therapeutic use*;
Coronary Disease/drug therapy*;
Drug Therapy, Combination;
Fibrinolytic Agents/therapeutic use*;
Humans;
Percutaneous Coronary Intervention;
Platelet Aggregation Inhibitors/therapeutic use*
- From:
Chinese Journal of Cardiology
2022;50(5):429-431
- CountryChina
- Language:Chinese
